Fabricator: Dragon Pharma, Europe
Unit: x1 vial
Strength: 10 mg/ml
If your order hasn’t arrived within 35 days after shipping, we’ll resend it for free.
Dragon Pharma Melanotan 2 10mg is a synthetic melanocortin peptide commonly used in laboratory research to explore pigmentation pathways, melanocyte activity, and MC1 receptor signaling.
Dragon Pharma Melanotan 2 is a cyclic synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) designed for research purposes. It acts as a selective agonist of the melanocortin-1 receptor (MC1R), which is involved in pigmentation and melanocyte activation. This peptide is extensively studied to investigate receptor signaling, pigmentation pathways, and cellular responses to melanocortin stimulation. As with all Dragon Pharma peptides, Melanotan 2 is lab-tested for purity and consistency, ensuring reproducible results in scientific studies.
Melanotan 2 functions by binding to MC1 receptors on melanocytes, stimulating melanin production and pigmentation-related cellular pathways. Research often focuses on receptor selectivity, peptide stability, and downstream signaling effects such as cAMP activation. This makes Dragon Pharma Melanotan 2 a valuable compound for studies examining skin pigmentation, photoprotection mechanisms, and melanocortin receptor pharmacology.
Reconstitution commonly involves bacteriostatic water to achieve desired study concentrations.
Form: Lyophilized powder for maximum stability.
Conditions:
Short-term: Refrigerate at 2–8°C.
Long-term: Store at -80°C for extended preservation.
Handling: Avoid freeze-thaw cycles; aliquot for experimental use. Protect from light, air, and moisture.
Solution Stability: Use sterile buffers (pH 5–6); store at 4°C for up to 30 days or freeze for longer periods.
For research purposes only. Not for human use or therapeutic applications.
Dragon Pharma Melanotan 2 undergoes analytical verification using HPLC and mass spectrometry to confirm peptide integrity, purity, and sequence accuracy. Each batch is produced under stringent research-grade standards to ensure reproducibility in laboratory studies.

Experimental concentrations vary depending on study design. Literature-based research frequently models Melanotan 2 doses in the range of 0.25–1 mg per administration for in vivo studies or cell culture assays. Administration is generally subcutaneous for in vivo models to observe receptor-mediated melanocortin effects.
Researchers sometimes combine Melanotan 2 with other melanocortin peptides to explore synergistic effects on MC receptor activity, signaling, and pigmentation pathways.
No post-cycle therapy (PCT) is required in laboratory experiments as Melanotan 2 does not interact with androgenic or suppressive endocrine pathways. Experimental protocols can be discontinued or modified without rebound effects.
Melanotan 2 is a synthetic peptide studied in laboratory settings for its effects on pigmentation pathways, melanocyte activity, and MC1 receptor signaling. It is not intended for human use.
Melanotan 2 binds to MC1 receptors, activating melanocytes and stimulating melanin production. Research studies often focus on receptor selectivity and downstream signaling pathways such as cAMP activation.
Yes, in research applications, Melanotan 2 can be studied alongside other melanocortin or signaling peptides to investigate receptor synergy and pigmentation modulation in experimental models.
Experimental dosing typically ranges from 0.25–1 mg per injection, depending on study design. These values are derived from literature and research protocols and are not intended as guidance for human use.
Melanotan 2 is available for research purchase through BuyDragonPharma.com, the official supplier of Dragon Pharma peptides.
Please log in to write Melanotan 2 10mg review.